Orum Therapeutics, Inc. (KOSDAQ:475830)
85,700
-400 (-0.46%)
Dec 10, 2025, 3:30 PM KST
308.10% (1Y)
| Market Cap | 1.82T |
| Revenue (ttm) | 25.48M |
| Net Income (ttm) | -36.88B |
| Shares Out | 21.16M |
| EPS (ttm) | -2,048.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 326,096 |
| Average Volume | 426,785 |
| Open | 82,300 |
| Previous Close | 86,100 |
| Day's Range | 81,100 - 87,100 |
| 52-Week Range | 15,950 - 87,100 |
| Beta | n/a |
| RSI | 74.07 |
| Earnings Date | Nov 14, 2025 |